InvestSMART

Acumentis Group Limited (ASX: ACU) - Announcements

- Current share price for ACU : $0.085

ASX company news and announcements for Acumentis Group Limited (ACU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acumentis Group Limited (ACU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acumentis Group Limited (ACU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acumentis Group Limited (ACU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$19 Response to ASX volume query 27 Apr 2012 5:57PM n/a $0.085 n/a
$19 Half Year Financial Report and Appendix 4D 28 Feb 2012 7:22PM $0.001 $0.085 risen by 8,400%
$19 Appendix 4C - quarterly 31 Jan 2012 1:31PM $0.001 $0.085 risen by 8,400%
$19 PROPOSED DIAGNOSTIC TECHNOLOGY ACQUISITION 25 Jan 2012 2:33PM $0.002 $0.085 risen by 4,150%
$19 Proposed BioHealth Acquisition 1 Dec 2011 8:24AM $0.001 $0.085 risen by 8,400%
$19 Appendix 4C - quarterly 27 Oct 2011 7:11PM $0.002 $0.085 risen by 4,150%
$19 Preliminary Final Report 30 Aug 2011 5:10PM $0.001 $0.085 risen by 8,400%
$19 Appendix 4C - quarterly 29 Jul 2011 12:46PM $0.001 $0.085 risen by 8,400%
$19 Proposed capital raising 27 May 2011 5:02PM $0.002 $0.085 risen by 4,150%
$19 Appendix 4C - quarterly 28 Apr 2011 2:25PM $0.002 $0.085 risen by 4,150%
$19 Appendix 4D - Half Yearly Report and Accounts 28 Feb 2011 3:34PM $0.001 $0.085 risen by 8,400%
$19 Appendix 4C - quarterly 31 Jan 2011 6:16PM $0.002 $0.085 risen by 4,150%
$19 Appendix 4C - quarterly 27 Oct 2010 4:56PM $0.003 $0.085 risen by 2,733.33%
$19 Preliminary Financial Report 30 Aug 2010 4:31PM $0.002 $0.085 risen by 4,150%
$19 Non-Renounceable Issue - Offer Document 27 Aug 2010 9:50AM $0.002 $0.085 risen by 4,150%
$19 s708A Notice 23 Aug 2010 3:01PM $0.002 $0.085 risen by 4,150%
$19 Hawaii Biotech Inc Update 23 Jul 2010 3:35PM $0.003 $0.085 risen by 2,733.33%
$19 Appendix 4C - quarterly 8 Jul 2010 4:12PM $0.003 $0.085 risen by 2,733.33%
$19 Business Update - HBI and Proposed Capital Raising 30 Jun 2010 9:57AM $0.004 $0.085 risen by 2,025%
$19 Non-Renounceable Rights Issue - shareholder letter 4 May 2010 9:48AM $0.008 $0.085 risen by 962.50%
$19 Appendix 4C - quarterly 30 Apr 2010 4:33PM $0.007 $0.085 risen by 1,114.29%
$19 Acuvax Undertakes Share Placement 23 Mar 2010 11:50AM $0.011 $0.085 risen by 672.73%
$19 Appendix 4D and Half Year Accounts 26 Feb 2010 4:47PM n/a $0.085 n/a
$19 Appendix 4C - quarterly 28 Jan 2010 2:41PM $0.014 $0.085 risen by 507.14%
$19 HBI Completes Phase 1 Trial 11 Jan 2010 2:13PM $0.017 $0.085 risen by 400%

476 - 500 of 601 results

Page 20 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.